Ovarian cancer is dangerous and difficult to treat, partly because it’s hard to diagnose early, and partly because it’s often resistant to existing drugs.

Hop onto TikTok and you'll find lots of videos of young people — mostly women — fake baking under the glowing UV lights of a tanning bed.

Women who receive risk-based breast cancer screening recommendations discussed those recommendations with their primary care providers more frequently than those who undergo annual screening.

Prostate adenocarcinoma is the most common type of prostate cancer, and adenocarcinoma simply means the cancer originated in the gland cells (the cells that normally produce the prostate fluid).

After the Senate failed to advance bills to address health care costs this week, House Republicans released proposed legislation late Friday that would not extend enhanced Affordable Care Act tax subsidies but would make other changes party leaders insist will improve Americans' access to health care.

Words no one wants to hear are “your cancer has come back.” No matter how long it’s been since your last treatment, learning your cancer has returned can leave you with a lot of questions.

As the deadline approaches for people to enroll in Marketplace coverage that starts January 1, 2026, the American Cancer Society Cancer Action Network (ACS CAN) is urging the Senate and the House to come together in a bipartisan way to pass legislation extending the enhanced premium tax credits and work to address the health care affordability crisis.

You’ve probably heard this story before: a local business, owned for decades by a family that has been deeply involved with the community, closes its doors due to being muscled out by a national big box store.

In 2026, the Trump administration will require U.S. cancer registries that receive federal funding to classify patients’ sex as male, female — or not stated/unknown.

Lore Gruenbaum sat down for an on-site interview with CURE at ASH to discuss the major themes shaping blood cancer care today, as well as expand on how the latest research is influencing advocacy priorities for Blood Cancer United.